MOLEKULE GROUP INC (MKUL) Fundamental Analysis & Valuation

NASDAQ:MKUL • US0077441055

Current stock price

0.0541 USD
-0.04 (-39.89%)
At close:
0.0519 USD
0 (-4.07%)
After Hours:

This MKUL fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. MKUL Profitability Analysis

1.1 Basic Checks

  • MKUL had negative earnings in the past year.
  • In the past year MKUL has reported a negative cash flow from operations.
MKUL Yearly Net Income VS EBIT VS OCF VS FCFMKUL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 -5M -10M -15M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -26.57%, MKUL is doing worse than 90.91% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of -81.87%, MKUL is doing worse than 86.36% of the companies in the same industry.
Industry RankSector Rank
ROA -26.57%
ROE -81.87%
ROIC N/A
ROA(3y)-52.87%
ROA(5y)N/A
ROE(3y)-66.34%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MKUL Yearly ROA, ROE, ROICMKUL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 0 50 -50 -100

1.3 Margins

  • MKUL has a Gross Margin of 37.90%. This is amongst the best in the industry. MKUL outperforms 81.82% of its industry peers.
  • MKUL does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 37.9%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MKUL Yearly Profit, Operating, Gross MarginsMKUL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 0 -2K -4K -6K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. MKUL Health Analysis

2.1 Basic Checks

  • MKUL does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for MKUL has been increased compared to 1 year ago.
  • There is no outstanding debt for MKUL. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
MKUL Yearly Shares OutstandingMKUL Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 5M 10M 15M
MKUL Yearly Total Debt VS Total AssetsMKUL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 5M 10M 15M 20M 25M

2.2 Solvency

  • Based on the Altman-Z score of -0.92, we must say that MKUL is in the distress zone and has some risk of bankruptcy.
  • MKUL has a worse Altman-Z score (-0.92) than 93.18% of its industry peers.
  • MKUL has a Debt/Equity ratio of 0.84. This is a neutral value indicating MKUL is somewhat dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.84, MKUL is in line with its industry, outperforming 40.91% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.84
Debt/FCF N/A
Altman-Z -0.92
ROIC/WACCN/A
WACC10.48%
MKUL Yearly LT Debt VS Equity VS FCFMKUL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 0 10M -10M 20M

2.3 Liquidity

  • A Current Ratio of 2.27 indicates that MKUL has no problem at all paying its short term obligations.
  • MKUL's Current ratio of 2.27 is in line compared to the rest of the industry. MKUL outperforms 56.82% of its industry peers.
  • MKUL has a Quick Ratio of 2.27. This is a bad value and indicates that MKUL is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Quick ratio value of 0.57, MKUL is not doing good in the industry: 90.91% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 2.27
Quick Ratio 0.57
MKUL Yearly Current Assets VS Current LiabilitesMKUL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 5M 10M 15M 20M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. MKUL Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 43.24% over the past year.
  • Looking at the last year, MKUL shows a very negative growth in Revenue. The Revenue has decreased by -62.90% in the last year.
EPS 1Y (TTM)43.24%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-105.41%
Revenue 1Y (TTM)-62.9%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%18814.29%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-274%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year14957.2%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MKUL Yearly Revenue VS EstimatesMKUL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 10M 20M 30M 40M 50M
MKUL Yearly EPS VS EstimatesMKUL Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 -0.5 -1 -1.5

More info and screens

Find the best growth stocksShow best growing peers

0

4. MKUL Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for MKUL. In the last year negative earnings were reported.
  • Also next year MKUL is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MKUL Price Earnings VS Forward Price EarningsMKUL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MKUL Per share dataMKUL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 -1 -1.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. MKUL Dividend Analysis

5.1 Amount

  • MKUL does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

MKUL Fundamentals: All Metrics, Ratios and Statistics

MOLEKULE GROUP INC

NASDAQ:MKUL (10/12/2023, 8:00:01 PM)

After market: 0.0519 0 (-4.07%)

0.0541

-0.04 (-39.89%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryBuilding Products
Industry Strength22.36
Industry Growth32.92
Earnings (Last)08-14
Earnings (Next)N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners22.18%
Ins Owner Change0%
Market Cap1.87M
Revenue(TTM)21.74M
Net Income(TTM)-33.32M
Analysts43.33
Price Target7.14 (13097.78%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-210.46%
Min EPS beat(2)-210.46%
Max EPS beat(2)-210.46%
EPS beat(4)1
Avg EPS beat(4)68.41%
Min EPS beat(4)-210.46%
Max EPS beat(4)511.77%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)8.17%
Min Revenue beat(2)8.17%
Max Revenue beat(2)8.17%
Revenue beat(4)1
Avg Revenue beat(4)-47.93%
Min Revenue beat(4)-96.08%
Max Revenue beat(4)8.17%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)99900%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.09
P/FCF N/A
P/OCF N/A
P/B 0.05
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.48
EYN/A
EPS(NY)-1.8
Fwd EYN/A
FCF(TTM)-1.01
FCFYN/A
OCF(TTM)-0.97
OCFYN/A
SpS0.63
BVpS1.17
TBVpS-0.74
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -26.57%
ROE -81.87%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 37.9%
FCFM N/A
ROA(3y)-52.87%
ROA(5y)N/A
ROE(3y)-66.34%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score1
Asset Turnover0.17
Health
Industry RankSector Rank
Debt/Equity 0.84
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 103.42%
Cap/Sales 5.57%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.27
Quick Ratio 0.57
Altman-Z -0.92
F-Score1
WACC10.48%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)43.24%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-105.41%
EPS Next Y-274%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-62.9%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%18814.29%
Revenue Next Year14957.2%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-108.74%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-283.61%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-391.39%
OCF growth 3YN/A
OCF growth 5YN/A

MOLEKULE GROUP INC / MKUL Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for MOLEKULE GROUP INC?

ChartMill assigns a fundamental rating of 1 / 10 to MKUL.


What is the valuation status of MOLEKULE GROUP INC (MKUL) stock?

ChartMill assigns a valuation rating of 0 / 10 to MOLEKULE GROUP INC (MKUL). This can be considered as Overvalued.


Can you provide the profitability details for MOLEKULE GROUP INC?

MOLEKULE GROUP INC (MKUL) has a profitability rating of 1 / 10.


Can you provide the financial health for MKUL stock?

The financial health rating of MOLEKULE GROUP INC (MKUL) is 2 / 10.


What is the expected EPS growth for MOLEKULE GROUP INC (MKUL) stock?

The Earnings per Share (EPS) of MOLEKULE GROUP INC (MKUL) is expected to decline by -274% in the next year.